Müller, Louise M. E.
Holmes, Matthew
Michael, Joanne L.
Scott, Gina B.
West, Emma J.
Scott, Karen J.
Parrish, Christopher
Hall, Kathryn
Stäble, Sina
Jennings, Victoria A.
Cullen, Matthew
McConnell, Stewart
Langton, Catherine
Tidswell, Emma L.
Shafren, Darren
Samson, Adel
Harrington, Kevin J.
Pandha, Hardev
Ralph, Christy
Kelly, Richard J.
Cook, Gordon
Melcher, Alan A.
Errington-Mais, Fiona http://orcid.org/0000-0003-2155-534X
Funding for this research was provided by:
Cancer research UK (A13244 and C16708)
Kay Kendall Leukaemia Fund (KKL1071)
Yorkshire Cancer Research (L374RA)
Article History
Received: 13 February 2019
Accepted: 6 June 2019
First Online: 1 July 2019
Ethics approval and consent to participate
: All blood samples were obtained from patients diagnosed with AML or patients taking part in the STORM Phase 1 clinical trial (NCT02043665/Keynote-200/VLA009A) following additional informed consent. Written, informed consent was obtained from all patients in accordance with local institutional ethics review and approval (Leeds Teaching Hospital NHS Trust; 06/Q1206/106).
: Not applicable.
: D.S is affiliated with Viralytics Ltd. No other author has any competing interests to declare.